3/A//SEC Filing
Frazier Life Sciences VIII, L.P. 3/A
Accession 0001209191-20-005857
CIK 0001787306other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:29 PM ET
Size
12.9 KB
Accession
0001209191-20-005857
Insider Transaction Report
Form 3/AAmended
FHM LIFE SCIENCES VIII, L.P.
10% Owner
Holdings
- 509,032
Common Stock
Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,074,467 underlying)Series A Preferred Stock
Exercise: $0.00→ Common Stock (6,360,272 underlying)Series B Preferred Stock
Exercise: $0.00→ Common Stock (2,099,019 underlying)
FHM LIFE SCIENCES VIII, L.L.C.
10% Owner
Holdings
Series A Preferred Stock
Exercise: $0.00→ Common Stock (6,360,272 underlying)Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,074,467 underlying)- 509,032
Common Stock
Series B Preferred Stock
Exercise: $0.00→ Common Stock (2,099,019 underlying)
Topper James N
10% Owner
Holdings
Series B Preferred Stock
Exercise: $0.00→ Common Stock (2,099,019 underlying)Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,074,467 underlying)Series A Preferred Stock
Exercise: $0.00→ Common Stock (6,360,272 underlying)- 509,032
Common Stock
Frazier Life Sciences VIII, L.P.
10% Owner
Holdings
- 509,032
Common Stock
Series A Preferred Stock
Exercise: $0.00→ Common Stock (6,360,272 underlying)Series B Preferred Stock
Exercise: $0.00→ Common Stock (2,099,019 underlying)Series C Preferred Stock
Exercise: $0.00→ Common Stock (1,074,467 underlying)
Footnotes (2)
- [F1]The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James Topper and Patrick Heron are the sole managing members of FHM LLC. Mr. Topper, FHM LP and FHM LLC disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his or its pecuniary interest therein, if any.
- [F2]Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the Issuer's initial public offering and has no expiration date.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001655827
Filing Metadata
- Form type
- 3/A
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:29 PM ET
- Size
- 12.9 KB